logo

Indian News

Share

whitehouse jun04 Today's Daily Dose brings you news about the finalists in 'Operation Warp Speed' COVID-19 vaccine program; FDA approval of Fitbit Flow ventilator for emergency use; an update on Cassava's phase IIb study of PTI-125 in patients with Alzheimer's disease and promising initial data from Kezar Life's MISSION trial.

pharma 032218 03jun20 Today's Daily Dose brings you news about Agenus' foray into COVID-19 drug development space; AMERI Holdings' progress in glioblastoma multiforme drug development; BrainStorm Cell's anticipated milestone related to its amyotrophic lateral sclerosis drug candidate; Citius Pharma's path forward for antibiotic lock solution; Novartis' revised FDA decision date and stock offerings of EvoFem and OraSure

logo jun02 Today's Daily Dose brings you news about Passport Health Plan failing to secure a new Medicaid managed care contract; Gilead's Remdesivir trial results in COVID-19 patients; Iterum missing trial goals in SURE2 study; Ocugen pulling the plug on ocular Graft vs. Host Disease; Novus' disappointing results in acute otitis media study.

xpovio june01 After winning FDA nod for Xpovio in the treatment of relapsed or refractory multiple myeloma, Karyopharm Therapeutics Inc. (KPTI) is now awaiting the FDA decision on the same drug for another indication - i.e., in relapsed/refractory diffuse large B-cell lymphoma.

Follow RTT